Innovative Medicine

Innovative Medicine

December 16, 2016

Janssen Submits Application Seeking FDA Approval Of Stelara® (Ustekinumab) For The Treatment Of Adolescents With Moderate To Severe Plaque Psoriasis

Learn more
Innovative Medicine

December 6, 2016

Late-breaking Phase 2 Ibrutinib Study in Chronic Graft-Versus-Host-Disease (cGVHD) Showed Complete or Partial Response in Up to Two-Thirds of Steroid Dependent or Refractory Patients

Learn more
Innovative Medicine

December 6, 2016

New Analysis Shows People with Cancer Who Received XARELTO® (rivaroxaban) for Blood Clots Had Fewer ER Visits and Lower Healthcare Costs than Those Given Standard Treatment

Learn more
Innovative Medicine

December 5, 2016

New Ibrutinib (IMBRUVICA®) Phase 2 Data Demonstrate Promise in Relapsed/Refractory Marginal Zone Lymphoma (MZL), a Rare, Incurable Type of Non-Hodgkin’s Lymphoma

Learn more
Innovative Medicine

December 5, 2016

Daratumumab (DARZALEX®) Combination Therapy Showed Consistent Clinical Benefit for Previously-Treated Patients with Multiple Myeloma

Learn more
Innovative Medicine

November 25, 2016

Janssen Submits Application To Ema Seeking Approval Of Anti-Interleukin-23 Monoclonal Antibody Guselkumab For The Treatment Of Moderate To Severe Plaque Psoriasis

Learn more
Innovative Medicine

November 21, 2016

DARZALEX® (daratumumab) Approved by U.S. FDA in Combination with Two Standard of Care Regimens for the Treatment of Patients with Multiple Myeloma Who Have Received At Least One Prior Therapy

Learn more
Global health equity

November 21, 2016

Johnson & Johnson Announces World Health Organization will Review Ebola Vaccine Regimen for Emergency Use Assessment and Listing (EUAL)

Preparations also underway to initiate first-in-human study for multivalent vaccine regimen to combat Ebola, Sudan and Marburg viruses

Learn more
Innovative Medicine

November 17, 2016

Janssen Submits Application to FDA Seeking Approval of Anti-Interleukin-23 Monoclonal Antibody Guselkumab for the Treatment of Moderate to Severe Plaque Psoriasis

Learn more